Request Deal Involvement

Singular led a €23m Series A round in Spore.Bio.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Chammas & Marcheteau

legal advisors

Chammas & Marcheteau

or

Principals

1ST KIND (FIRST KIND)

bidder

1ST KIND (FIRST KIND)

SPORE.BIO

target

SPORE.BIO

INSTITUT PASTEUR

bidder

INSTITUT PASTEUR

POINT72 VENTURES

bidder

POINT72 VENTURES

SINGULAR

bidder

SINGULAR

STATION F

bidder

STATION F

LORD DAVID PRIOR

bidder

LORD DAVID PRIOR

LOCALGLOBE

bidder

LOCALGLOBE

NO LABEL VENTURES (NLV)

bidder

NO LABEL VENTURES (NLV)

FAMILLE C PARTICIPATIONS

bidder

FAMILLE C PARTICIPATIONS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Singular led a €23m Series A round in Spore.Bio.